Soft Tissue Sarcoma
Latest News

December 8th 2023
By Rose McNulty
Mrinal M. Gounder, MD, a sarcoma oncologist at Memorial Sloan Kettering Cancer Center and lead investigator of the phase 3 DeFi trial of nirogacestat in desmoid tumors, discusses the drug's recent FDA approval and potential impacts on desmoid tumor treatment going forward.
Advertisement
CME Content
Advertisement
Advertisement
Advertisement













































